These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 21820356)

  • 1. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
    Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
    Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
    Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
    PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease.
    Davis RL; Liang C; Edema-Hildebrand F; Riley C; Needham M; Sue CM
    Neurology; 2013 Nov; 81(21):1819-26. PubMed ID: 24142477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
    Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
    J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia).
    Salehi MH; Kamalidehghan B; Houshmand M; Aryani O; Sadeghizadeh M; Mossalaeie MM
    Mol Biol Rep; 2013 Nov; 40(11):6495-9. PubMed ID: 24078096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
    Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
    Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
    J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
    Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
    Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
    Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
    Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
    Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 as a biomarker for long-term complications in organic acidemias.
    Molema F; Jacobs EH; Onkenhout W; Schoonderwoerd GC; Langendonk JG; Williams M
    J Inherit Metab Dis; 2018 Nov; 41(6):1179-1187. PubMed ID: 30159853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
    Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
    Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
    Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
    Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency.
    Motlagh Scholle L; Lehmann D; Joshi PR; Zierz S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders.
    Suomalainen A
    Expert Opin Med Diagn; 2013 Jul; 7(4):313-7. PubMed ID: 23782039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis.
    Lin Y; Ji K; Ma X; Liu S; Li W; Zhao Y; Yan C
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1204-1213. PubMed ID: 32585080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for mitochondrial energy metabolism diseases.
    Boenzi S; Diodato D
    Essays Biochem; 2018 Jul; 62(3):443-454. PubMed ID: 29980631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.